<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-903-SII-38257</iati-identifier>
  <reporting-org ref="XM-DAC-903" type="40">
   <narrative xml:lang="EN">International Finance Corporation</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Ascendis Project</narrative>
  </title>
  <description type="2">
   <narrative xml:lang="EN">The Project is expected to (i) significantly increase access to quality pharmaceutical products in developing countries; (ii) considerably increase patients reached (iii) support UN/NGO organizations health and relief efforts, as Remedica is a supplier to key NGOs such as UNICEF, the United Nations Relief and Works Agency for Palestine Refugees (UNRWA), Medicins Sans Frontieres, International Red Cross among others; and (iv) help develop the private sector, since the Company&apos;&apos;s activities span across the value chain.</narrative>
  </description>
  <description type="1">
   <narrative xml:lang="EN">The project consists of an equity investment of up to US$30 million in Ascendis Health Limited (Ascendis or the Company), a publicly listed South African based pharmaceutical, medical device and consumer brands company. The project will provide the Company with funding to finance the acquisitions of (i) 100% of Remedica, a generic pharmaceutical brands company; and (ii) 100% of Scitec, a leading sports nutrition company that owns one of the top three brands in Europe.</narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">ASCENDIS HEALTH LIMITED</narrative>
  </participating-org>
  <participating-org activity-id="XM-DAC-903-SII-38257" ref="XM-DAC-903" role="1" type="40"></participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2016-05-11" type="1"></activity-date>
  <activity-date iso-date="2016-08-18" type="2"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">International Finance Corporation</narrative>
   </organisation>
   <telephone>+12024733800</telephone>
   <email>ccspg@ifc.org</email>
   <website>www.ifc.org</website>
   <mailing-address>
    <narrative xml:lang="EN">2121 Pennsylvania Avenue, NW Washington DC 20433</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">Contact Person: Ms Lara Grieve  Company Name: COAST2COAST Address: 22 Sloane Street, Bryanston, Johannesburg, South Africa. Email:  mailto:Lara@c2c.co.za  Phone: +27 84 645 7206</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">Contact Person: Ms Lara Grieve  Company Name: COAST2COAST Address: 22 Sloane Street, Bryanston, Johannesburg, South Africa. Email:  mailto:Lara@c2c.co.za  Phone: +27 84 645 7206</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="ZA" percentage="100">
   <narrative xml:lang="EN">South Africa</narrative>
  </recipient-country>
  <location ref="ZA-South Africa">
   <location-reach code="1"></location-reach>
   <location-id code="1453782" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="EN">Remedica has sales mainly into developing markets in the Middle East and Africa and also into parts of Europe, with manufacturing facilities located in Cyprus. Scitec has sales across Europe, with strong market positions in Germany, France, Hungary, Spain, Italy and Poland.</narrative>
   </name>
   <description>
    <narrative xml:lang="EN">Location description</narrative>
   </description>
   <activity-description>
    <narrative xml:lang="EN">A description that qualifies the activity taking place at the location.</narrative>
   </activity-description>
   <administrative code="1453782" level="1" vocabulary="G1"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>-29.0000000000 24.0000000000</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="1"></location-class>
   <feature-designation code="ADMF"></feature-designation>
  </location>
  <sector code="621" percentage="100" vocabulary="11" vocabulary-uri="http://www.census.gov/cgi-bin/sssd/naics/naicsrch?chart=2012">
   <narrative xml:lang="EN">S-AC - Other Health Services</narrative>
  </sector>
  <country-budget-items vocabulary="1">
   <budget-item code="7.2.1" percentage="100" vocabulary="1">
    <description>
     <narrative xml:lang="EN">Total: $30.00 million</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="6"></collaboration-type>
  <default-flow-type code="35"></default-flow-type>
  <default-finance-type code="510"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget type="1">
   <period-start iso-date="2016-05-11"></period-start>
   <period-end iso-date="2016-06-30"></period-end>
   <value currency="USD" value-date="2016-05-11">30000000</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2016-05-11"></transaction-date>
   <value currency="USD" value-date="2016-05-11">30000000</value>
   <receiver-org>
    <narrative xml:lang="EN">ASCENDIS HEALTH LIMITED</narrative>
   </receiver-org>
   <flow-type code="35"></flow-type>
   <finance-type code="510"></finance-type>
  </transaction>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/project-detail/SII/38257/ascendis-project">
   <title>
    <narrative xml:lang="EN">Summary of Investment Information - Anticipated Impact Measurement &amp; Monitoring (AIMM) Assessment and Main Environmental &amp; Social Risks and Impacts of the Project</narrative>
   </title>
   <category code="A01"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/project-detail/SII/38257/ascendis-project">
   <title>
    <narrative xml:lang="EN">Summary of Investment Information</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <result aggregation-status="1" type="1">
   <title>
    <narrative xml:lang="EN">Development Results</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Development Result Description</narrative>
   </description>
   <indicator ascending="1" measure="1">
    <title>
     <narrative xml:lang="EN">Indicator</narrative>
    </title>
    <description>
     <narrative xml:lang="EN">Affected communities protection(%)</narrative>
    </description>
    <reference code="Affected communities protection(%)" vocabulary="8"></reference>
    <baseline value="Not Available" year="2019">
     <comment>
      <narrative xml:lang="EN">Affected communities protection(%)</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-01-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target value="0">
      <location ref="ZA-South Africa"></location>
      <comment>
       <narrative xml:lang="EN">The Project is expected to (i) significantly increase access to quality pharmaceutical products in developing countries; (ii) considerably increase patients reached (iii) support UN/NGO organizations health and relief efforts, as Remedica is a supplier to key NGOs such as UNICEF, the United Nations Relief and Works Agency for Palestine Refugees (UNRWA), Medicins Sans Frontieres, International Red Cross among others; and (iv) help develop the private sector, since the Company&apos;&apos;s activities span across the value chain.</narrative>
      </comment>
     </target>
     <actual value="Not Available">
      <location ref="ZA-South Africa"></location>
      <comment>
       <narrative xml:lang="EN">The Project is expected to (i) significantly increase access to quality pharmaceutical products in developing countries; (ii) considerably increase patients reached (iii) support UN/NGO organizations health and relief efforts, as Remedica is a supplier to key NGOs such as UNICEF, the United Nations Relief and Works Agency for Palestine Refugees (UNRWA), Medicins Sans Frontieres, International Red Cross among others; and (iv) help develop the private sector, since the Company&apos;&apos;s activities span across the value chain.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="1">
    <title>
     <narrative xml:lang="EN">Indicator</narrative>
    </title>
    <description>
     <narrative xml:lang="EN">Human Resources Policies and Procedures(%)</narrative>
    </description>
    <reference code="Human Resources Policies and Procedures(%)" vocabulary="8"></reference>
    <baseline value="Not Available" year="2019">
     <comment>
      <narrative xml:lang="EN">Human Resources Policies and Procedures(%)</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-01-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target value="0">
      <location ref="ZA-South Africa"></location>
      <comment>
       <narrative xml:lang="EN">The Project is expected to (i) significantly increase access to quality pharmaceutical products in developing countries; (ii) considerably increase patients reached (iii) support UN/NGO organizations health and relief efforts, as Remedica is a supplier to key NGOs such as UNICEF, the United Nations Relief and Works Agency for Palestine Refugees (UNRWA), Medicins Sans Frontieres, International Red Cross among others; and (iv) help develop the private sector, since the Company&apos;&apos;s activities span across the value chain.</narrative>
      </comment>
     </target>
     <actual value="Not Available">
      <location ref="ZA-South Africa"></location>
      <comment>
       <narrative xml:lang="EN">The Project is expected to (i) significantly increase access to quality pharmaceutical products in developing countries; (ii) considerably increase patients reached (iii) support UN/NGO organizations health and relief efforts, as Remedica is a supplier to key NGOs such as UNICEF, the United Nations Relief and Works Agency for Palestine Refugees (UNRWA), Medicins Sans Frontieres, International Red Cross among others; and (iv) help develop the private sector, since the Company&apos;&apos;s activities span across the value chain.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="1">
    <title>
     <narrative xml:lang="EN">Indicator</narrative>
    </title>
    <description>
     <narrative xml:lang="EN">Occupational Health and Safety(%)</narrative>
    </description>
    <reference code="Occupational Health and Safety(%)" vocabulary="8"></reference>
    <baseline value="Not Available" year="2019">
     <comment>
      <narrative xml:lang="EN">Occupational Health and Safety(%)</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-01-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target value="0">
      <location ref="ZA-South Africa"></location>
      <comment>
       <narrative xml:lang="EN">The Project is expected to (i) significantly increase access to quality pharmaceutical products in developing countries; (ii) considerably increase patients reached (iii) support UN/NGO organizations health and relief efforts, as Remedica is a supplier to key NGOs such as UNICEF, the United Nations Relief and Works Agency for Palestine Refugees (UNRWA), Medicins Sans Frontieres, International Red Cross among others; and (iv) help develop the private sector, since the Company&apos;&apos;s activities span across the value chain.</narrative>
      </comment>
     </target>
     <actual value="Not Available">
      <location ref="ZA-South Africa"></location>
      <comment>
       <narrative xml:lang="EN">The Project is expected to (i) significantly increase access to quality pharmaceutical products in developing countries; (ii) considerably increase patients reached (iii) support UN/NGO organizations health and relief efforts, as Remedica is a supplier to key NGOs such as UNICEF, the United Nations Relief and Works Agency for Palestine Refugees (UNRWA), Medicins Sans Frontieres, International Red Cross among others; and (iv) help develop the private sector, since the Company&apos;&apos;s activities span across the value chain.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="1">
    <title>
     <narrative xml:lang="EN">Indicator</narrative>
    </title>
    <description>
     <narrative xml:lang="EN">Organizational capacity and Management Programs(%)</narrative>
    </description>
    <reference code="Organizational capacity and Management Programs(%)" vocabulary="8"></reference>
    <baseline value="Not Available" year="2019">
     <comment>
      <narrative xml:lang="EN">Organizational capacity and Management Programs(%)</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-01-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target value="0">
      <location ref="ZA-South Africa"></location>
      <comment>
       <narrative xml:lang="EN">The Project is expected to (i) significantly increase access to quality pharmaceutical products in developing countries; (ii) considerably increase patients reached (iii) support UN/NGO organizations health and relief efforts, as Remedica is a supplier to key NGOs such as UNICEF, the United Nations Relief and Works Agency for Palestine Refugees (UNRWA), Medicins Sans Frontieres, International Red Cross among others; and (iv) help develop the private sector, since the Company&apos;&apos;s activities span across the value chain.</narrative>
      </comment>
     </target>
     <actual value="Not Available">
      <location ref="ZA-South Africa"></location>
      <comment>
       <narrative xml:lang="EN">The Project is expected to (i) significantly increase access to quality pharmaceutical products in developing countries; (ii) considerably increase patients reached (iii) support UN/NGO organizations health and relief efforts, as Remedica is a supplier to key NGOs such as UNICEF, the United Nations Relief and Works Agency for Palestine Refugees (UNRWA), Medicins Sans Frontieres, International Red Cross among others; and (iv) help develop the private sector, since the Company&apos;&apos;s activities span across the value chain.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="1">
    <title>
     <narrative xml:lang="EN">Indicator</narrative>
    </title>
    <description>
     <narrative xml:lang="EN">Stakeholder Engagement(%)</narrative>
    </description>
    <reference code="Stakeholder Engagement(%)" vocabulary="8"></reference>
    <baseline value="Not Available" year="2019">
     <comment>
      <narrative xml:lang="EN">Stakeholder Engagement(%)</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-01-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target value="0">
      <location ref="ZA-South Africa"></location>
      <comment>
       <narrative xml:lang="EN">The Project is expected to (i) significantly increase access to quality pharmaceutical products in developing countries; (ii) considerably increase patients reached (iii) support UN/NGO organizations health and relief efforts, as Remedica is a supplier to key NGOs such as UNICEF, the United Nations Relief and Works Agency for Palestine Refugees (UNRWA), Medicins Sans Frontieres, International Red Cross among others; and (iv) help develop the private sector, since the Company&apos;&apos;s activities span across the value chain.</narrative>
      </comment>
     </target>
     <actual value="Not Available">
      <location ref="ZA-South Africa"></location>
      <comment>
       <narrative xml:lang="EN">The Project is expected to (i) significantly increase access to quality pharmaceutical products in developing countries; (ii) considerably increase patients reached (iii) support UN/NGO organizations health and relief efforts, as Remedica is a supplier to key NGOs such as UNICEF, the United Nations Relief and Works Agency for Palestine Refugees (UNRWA), Medicins Sans Frontieres, International Red Cross among others; and (iv) help develop the private sector, since the Company&apos;&apos;s activities span across the value chain.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
